Medpedia

News & Analysis » Health News » We Are Survivors

FDA Okays New Drug Combo for Asthma

By COPDsurvivor
Jun 30, 10 09:07AM | 0 comments
The FDA has approved the inhaled corticosteroid/beta2-agonist combination drug mometasone furoate and formoterol fumarate dihydrate (DULERA) for the treatment of asthma in patients 12 and older.

Drug approval was based on safety efficacy data from three phase III trials (with a total of 1,913 patients) which tested short- and long-term effects of treatment.

Read More...
Link to original post

Comments

To add a comment to the original post, click here.

You must be signed in to post a comment.

Sign in now

There are no comments for this post.

Contributor

By Timothy R Kelley
From We Are Survivors

More from this contributor

»» See all Posts

Browse News & Analysis by Channel

Browse News & Analysis by Keywords

Technology Obesity Diabetes Mellitus Nutrition Medicine Healthcare Health Care Reform Aging and End of Life Attention Deficit Disorder with Hyperactivity Information Science Medical Students Health Emergency Medicine Psychiatry Medical education Global Health Research Alzheimer Disease Health 2.0 Women's Health Health Policy & Management Breast Neoplasms Dementia Pain Public Health
» See all
Medpedia Portals - Adult Primary Care Allergy and Immunology Anatomy Cardiology Emergency Medicine Endocrinology Epidemiology Gastroenterology and Hepatology General Medicine Infectious Diseases Internal Medicine Neurology & Neurobiology Nutrition OB/GYN and Reproductive Health Oncology Orthopedics Pathology Pediatrics Pharmacology Psychiatry Public Health Pulmonology Rheumatology Women's Health
Editor Directory - browse by last initial
ABCDEFGHIJKLMNOPQRSTUVWXYZ
Professional Directory - browse by last initial
ABCDEFGHIJKLMNOPQRSTUVWXYZ
About Medpedia | Privacy Policy | Terms of Use | Contact | Press | FAQ | Medical School Network
Content on this page is the sole copyright of the author.
Cancel
Cancel